{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:13:04Z","timestamp":1786993984543,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.mayocp.2014.11.013","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T00:15:17Z","timestamp":1422836117000},"page":"216-223","source":"Crossref","is-referenced-by-count":11,"title":["The Association Between Thromboembolic Complications and Blood Group in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"90","author":[{"given":"Jodi M.","family":"Blustin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"McBane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matylda","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Ammash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Sochor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar E.","family":"Wysokinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.mayocp.2014.11.013_bib1","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1056\/NEJM197112092852404","article-title":"Blood groups, myocardial infarction and angina pectoris among 10,000 adult males","volume":"285","author":"Medalie","year":"1971","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2014.11.013_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1538-7836.2007.02818.x","article-title":"ABO(H) blood groups and vascular disease: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"10.1016\/j.mayocp.2014.11.013_bib3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCULATIONAHA.107.722827","article-title":"von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes","volume":"117","author":"Spiel","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mayocp.2014.11.013_bib4","first-page":"107","article-title":"von Willebrand factor and endothelial damage in essential hypertension","volume":"7","author":"Blann","year":"1993","journal-title":"J\u00a0Hum Hypertens"},{"issue":"10","key":"10.1016\/j.mayocp.2014.11.013_bib5","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1537-2995.2006.00975.x","article-title":"ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?","volume":"46","author":"Jenkins","year":"2006","journal-title":"Transfusion"},{"issue":"8943","key":"10.1016\/j.mayocp.2014.11.013_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mayocp.2014.11.013_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-3148.2001.00315.x","article-title":"The relationship between ABO histo-blood group, factor VIII and von Willebrand factor","volume":"11","author":"O\u2019Donnell","year":"2001","journal-title":"Transfus Med"},{"issue":"2","key":"10.1016\/j.mayocp.2014.11.013_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.blre.2005.02.002","article-title":"Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease","volume":"20","author":"Millar","year":"2006","journal-title":"Blood Rev"},{"issue":"7","key":"10.1016\/j.mayocp.2014.11.013_bib9","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A\u00a0shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.mayocp.2014.11.013_bib10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.mayocp.2014.11.013_bib11","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.105.553438","article-title":"Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study","volume":"112","author":"Fang","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mayocp.2014.11.013_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1160\/TH07-12-0734","article-title":"Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation","volume":"99","author":"McBane","year":"2008","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.mayocp.2014.11.013_bib13","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.107.501825","article-title":"Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation","volume":"39","year":"2008","journal-title":"Stroke"},{"issue":"15","key":"10.1016\/j.mayocp.2014.11.013_bib14","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000033220.97592.9A","article-title":"Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors","volume":"106","author":"Conway","year":"2002","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.mayocp.2014.11.013_bib15","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","article-title":"Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation","volume":"107","author":"Conway","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocp.2014.11.013_bib16","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1161\/ATVBAHA.111.232991","article-title":"Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation","volume":"31","author":"Ammash","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"10.1016\/j.mayocp.2014.11.013_bib17","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.mayocp.2014.11.013_bib18","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.echo.2007.01.016","article-title":"Does left atrial appendage peak emptying flow velocity predict the electrical energy required to achieve successful direct-current cardioversion in patients with persistent atrial fibrillation?","volume":"20","author":"Melduni","year":"2007","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"4","key":"10.1016\/j.mayocp.2014.11.013_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ahj.2009.12.043","article-title":"Predicting left atrial thrombi in atrial fibrillation","volume":"159","author":"Wysokinski","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.mayocp.2014.11.013_bib20","unstructured":"Blood types in the U.S. Stanford University Blood Center website. http:\/\/bloodcenter.stanford.edu\/education\/blood_types.html. Accessed August 1,\u00a02010."},{"issue":"1","key":"10.1016\/j.mayocp.2014.11.013_bib21","first-page":"89","article-title":"Factor VIII and factor IX in a twin population: evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"},{"issue":"9250","key":"10.1016\/j.mayocp.2014.11.013_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(00)03541-8","article-title":"The genetics of haemostasis: a twin study","volume":"357","author":"de Lange","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mayocp.2014.11.013_bib23","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.mayocp.2014.11.013_bib24","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1161\/01.STR.0000230307.03438.94","article-title":"Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke","volume":"37","author":"Marder","year":"2006","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.mayocp.2014.11.013_bib25","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1538-7836.2004.00899.x","article-title":"Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi","volume":"2","author":"Wysokinski","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.mayocp.2014.11.013_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000016023","article-title":"Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies","volume":"10","author":"Hart","year":"2000","journal-title":"Cerebrovasc Dis"},{"issue":"13","key":"10.1016\/j.mayocp.2014.11.013_bib27","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2014.11.013_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.amjhyper.2004.09.003","article-title":"High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: relationship to thrombogenesis and endothelial damage\/dysfunction","volume":"18","author":"Lee","year":"2005","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.mayocp.2014.11.013_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00001721-200307000-00001","volume":"14","author":"Felmeden","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"10.1016\/j.mayocp.2014.11.013_bib30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1538-7836.2005.01778.x","article-title":"Genetic influence on thrombotic risk markers in the elderly\u2014a Danish twin study","volume":"4","author":"Bladbjerg","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.mayocp.2014.11.013_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00019501-199602000-00008","article-title":"von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis","volume":"7","author":"Blann","year":"1996","journal-title":"Coron Artery Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2014.11.013_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/BJ20070404","article-title":"Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues","volume":"405","author":"Fish","year":"2007","journal-title":"Biochem J"},{"issue":"24","key":"10.1016\/j.mayocp.2014.11.013_bib33","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.108.792986","article-title":"Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the Framingham offspring study","volume":"118","author":"Frankel","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.mayocp.2014.11.013_bib34","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1538-7836.2003.00359.x","article-title":"Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?","volume":"1","author":"Brown","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"10.1016\/j.mayocp.2014.11.013_bib35","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1586\/14779072.2014.960851","article-title":"Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation","volume":"12","author":"Blustin","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961401043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961401043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T08:02:13Z","timestamp":1566288133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961401043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S002561961401043X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2014.11.013","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}